Veriheal

APRIL 11, 2022

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. This means that the medical and scientific communities can now celebrate broader access to research for the production of pharmaceutical products that are safer than smokable or vaporizable cannabis. Is the future exciting? Absolutely.”

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. Cannabis is a really special case.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

NORML

JUNE 13, 2019

Millions of Americans are legally replacing pharmaceuticals with cannabis and the question of affordability has become critical. Certain conditions require more cannabinoids than others. The reality is that cannabinoids have very individualized effects on human beings. Are you paying too much for medical marijuana?

Marijuana 278

Marijuana Dispensary Patients Retail 278

FloridaMarijuana.net

JUNE 22, 2018

Patients who suffer from this condition also face other symptoms that are painful, inconvenient -to say the least, -and lower their quality of life. Many of these medications have serious side effects that only add on to the stress, pain, and frustration that patients already feel due to their condition.

Hybrid 189

Hybrid Marijuana Sativa Nerve Pain 189

MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Project CBD

MAY 3, 2023

Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?

Cannabinoids 213

Cannabinoids Sleep Clinical Trials CBD 213

Veriheal

AUGUST 12, 2021

million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). Patients who suffer from epilepsy , which affects some 3.4 CBD, which constitutes a $2,770.8 It goes by the name of “artisanal CBD.” .

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. This report has been compiled to assist interested parties in understanding the market for the medical use of cannabinoids and where it may be heading. GW Pharmaceuticals.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

FloridaMarijuana.net

AUGUST 15, 2018

The endocannabinoid system consists of cannabinoid receptors all over the body. When the body is defensive against trauma, this system begins to fail, resulting in physical, mental and/or neurological conditions. This system enables a connection between body and mind, signaling to all other systems when something feels good or bad.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. About InMed: InMed Pharmaceuticals is a clinical stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

DECEMBER 15, 2021

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Pharmaceutical 52

Pharmaceutical Cannabinoids Business Extraction 52

Veriheal

OCTOBER 13, 2020

Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. Crohn’s Disease is also a condition that causes inflammation, but it affects the lining of the digestive tract, which can then spread deeply into the affected tissues. .

Digestion 124

Digestion Treatment Conditions Research and Development 124

FloridaMarijuana.net

OCTOBER 5, 2018

THC and CBD are two popular cannabinoids, and have been used medicinally for centuries. In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. Cannabis possesses healing properties which can aid in a patient’s overall healthcare routine.

Terpenes 181

Terpenes Strains Oil Medicine 181

Cannabis Law Report

AUGUST 27, 2021

Nextleaf Solutions’s technologies are focused on transforming cannabis or hemp biomass to a standardized cannabinoid oil as efficiently as possible. It’s capable of extracting cannabinoids from cannabis biomass in a non-flammable and inexpensive co-solvent system using a flow-through ultrasonic extraction system. Flawless Strategy.

Extraction 98

Extraction Cannabinoids Research and Development Oil 98

FloridaMarijuana.net

AUGUST 15, 2018

While PTSD can be treated with therapies and pharmaceutical medications, those are not always successful and additional treatments are necessary. Medical marijuana and cannabinoids can be used to treat a patient’s physical and psychological health, alleviating the symptoms of PTSD. Get your Florida Medical Marijuana Card.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

CannaMD

FEBRUARY 19, 2020

Post-traumatic stress disorder (PTSD) is a condition most often associated with military veterans, but it is not confined to wartime experiences. Medical Marijuana: More Effective Than Pharmaceuticals? To date, there is no pharmaceutical product targeted specifically for the treatment of PTSD.

CBD 108

CBD Pharmaceutical Research and Development Conditions 108

FloridaMarijuana.net

OCTOBER 11, 2018

In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. As researchers dive into the depths of the cannabinoid system it is becoming clear that cannabis terpenes are just as vital to a plant’s efficacy as are THC and CBD.

Terpenes 172

Terpenes Strains Medicine Oil 172

United Patients Group

FEBRUARY 7, 2023

Inflammation can lead to a wide range of diseases and conditions, including heart disease, arthritis and cancer. This article will cover some common uses for medical cannabis when treating inflammation or pain along with what other ingredients might be helpful in reducing symptoms related to these conditions!

Cannabinoids 116

Cannabinoids Chronic Pain Terpenes THC 116

Cannabis Law Report

NOVEMBER 12, 2021

THE Chairman of a recently-listed UK pharmaceutically-focused cannabis company has stood down after a breach of market rules. Neil Mahapatra is a co-founder of the Oxford Cannabinoid Technologies (OCT) which floated on the LSE in the May this year, he is also founder of UK venture capital business Kingsley Capital Partners (KCP).

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

Cannabis Law Report

JANUARY 3, 2022

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. There is a large and growing need to treat acute cannabinoid intoxication with 1.7 million cannabinoid-related emergency department visits in the U.S. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

Project CBD

SEPTEMBER 12, 2023

He would undergo a dozen surgeries and consume a steady diet of prescription narcotics and other pharmaceuticals. There’s no doubt that cannabis helps Rosenfeld’s condition, but it’s not a cure. When scientists blocked the CB1 cannabinoid receptor, ketamine did not prevent pain.

Chronic Pain 233

Chronic Pain Treatment Cannabinoids Research and Development 233

The Cannigma

FEBRUARY 1, 2023

Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition. Even if a cannabinoid has shown promise on one cancer line, that doesn’t mean it will work for all cancers – even if it’s within the same organ system. 1 So can cannabis cure cancer?

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

FloridaMarijuana.net

AUGUST 9, 2018

This means that often pharmaceutical medications are experimental. The endocannabinoid system consists of cannabinoid receptors all over the body. When the body is defensive against trauma or illness, this system begins to fail, resulting in physical, mental and/or neurological conditions.

Marijuana 190

Marijuana Patients Clinical Trials Treatment 190

Canna Care Docs

NOVEMBER 4, 2024

Patients dealing with chronic pain from numerous conditions are finding relief in cannabis. Healthcare, tennis player and injured black man or athlete with muscle pain or inflammation after exercise or workout Chronic Pain and Challenges Chronic pain is a long-lasting condition that persists for more than 3-6 months, sometimes lasting years.

Chronic Pain 111

Chronic Pain Nerve Pain Treatment Cannabinoids 111

FloridaMarijuana.net

JUNE 19, 2018

When family members are sick or suffering, its natural to seek relief for their conditions and ailments. Sometimes traditional veterinary pharmaceuticals may not always be effective for dogs and cats and the side-effects may interfere with a pet’s quality of life. When a pet is ill, it can feel like a member of the family is suffering.

Pets 186

Pets CBD Tincture Oil 186

Cannabis Law Report

JULY 12, 2019

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Veriheal

MARCH 9, 2021

A team of researchers at Australia’s University of Queensland and at Botanix Pharmaceuticals Limited found, for the first time, that CBD is effective in killing Gram-negative bacteria which could mean that a new class of antibiotics can be developed for bacteria which is resistant to other forms of pharmaceutical medications. .

Research and Development 110

Research and Development Pharmaceutical Cannabinoids CBD 110

Cannabis Law Report

AUGUST 29, 2021

This export also validates the emergence of the global cannabinoid sector with reliance on quality, traceability and sustainability that Avicanna ’s Aureus products offer. To the knowledge of the Company, it carries out its operations in compliance with all applicable laws in the jurisdictions in which it operates.

Extraction 98

Extraction Supply Chain Research and Development CBD 98

Veriheal

APRIL 7, 2022

As with many other conditions, there is a lack of research regarding the use of MMJ as an alternative treatment to relieve symptoms of MS. . The researchers suggest that the cannabinoids in MMJ can assist with the treatment of MS, contributing “add-on immunosuppressive, analgesic, neuroprotective and remyelinative effects.”

Patients 98

Patients Treatment Cannabinoids Pharmaceutical 98

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use. CBD for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Veriheal

JANUARY 26, 2023

Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. Most commonly, pharmaceutical medication is prescribed to regulate moods. But there may be some good news for those coping with this mental health issue.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

Cannabis Law Report

AUGUST 6, 2021

CBD, which is an abbreviation for Cannabidiol, is one of Cannabis’s primary components – one of its primary Cannabinoids. Cannabinoids are the naturally occurring compounds found in the Cannabis plant. There are over 480 different Cannabinoids in the Cannabis plant. It is non-psychoactive and has a multitude of health benefits.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105

MJ Business Attorneys

JUNE 29, 2018

The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome. DEA, the DEA expressed in their brief that they do not wish to control cannabinoids, but rather only those cannabinoids derived from the flowers and resins of a cannabis plant above.3%

DEA 113

DEA CBD Pharmaceutical Research and Development 113

The Cannigma

FEBRUARY 4, 2021

Dronabinol, the pharmaceutical name for ?9-tetrahydrocannabinol While the approval covered a synthetic version of the most famous cannabinoid, it is chemically indistinguishable from the version naturally produced by the cannabis plant. The FDA has approved (separate) drugs with the active ingredients THC and CBD. . Shutterstock).

Cannabinoids 145

Cannabinoids THC Blood Pressure Conditions 145

Kind Meds (Cannabis Education Blog)

SEPTEMBER 1, 2020

As of 2020, more states allow for some type of legal cannabis use than do not, and there is growing public interest in expanding the number of medical conditions that qualify for medical marijuana approval. Understanding Cannabinoids and Endocannabinoids. How Does CBD Improve Mental Health Symptoms?

Treatment 122

Treatment Research and Development CBD THC 122

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. Epidyolex has been approved as a treatment option for children as young as two with Lennox-Gastaut syndrome or Dravet syndrome – difficult-to-treat conditions that can cause multiple seizures a day. ” Source BBC: [link].

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55